Know What Lies in the Future of Clinical Trial Management Industry

The time frame considered for the study is as follows:

• Base Year: 2016
• Forecast Period: 2017–2022

Objectives of the study are:

• To define, describe, segment, and forecast the global clinical trial management systems market by type, delivery mode, component, end user, and region
  
• To provide detailed information regarding the major factors influencing the growth of the global CTMS market (drivers, restraints, opportunities, and challenges)
  
• To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
  
• To analyze the growth opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  
• To forecast the market value of market segments with respect to the four key regions, namely, North America (US, and Canada), Europe (Germany, UK, France and RoE), Asia Pacific (China, Japan, India and RoAPAC), and the Rest of the World
  
• To profile the key players in the global CTMS market and comprehensively analyze their market rank and core competencies2
  
• To track and analyze competitive developments such as product launches and enhancements; partnerships, agreements, and collaborations; mergers and acquisitions; and expansions in the global clinical trial management system market

                           Download the PDF Brochure for More Information@ http://bit.ly/2xJt7iR

The enterprise CTMS segment is estimated to account for the largest share of the CTMS market by type in 2017

The CTMS market is segmented into enterprise CTMS and site CTMS on the basis of type. The enterprise CTMS segment is expected to command the largest share of the global CTMS market in 2017, and is expected to grow at the highest CAGR in the forecast period. This is attributed to the widespread adoption of enterprise CTMS by majority of the end users.

The pharmaceutical and biopharmaceutical companies segment is expected to hold the largest share of the market in 2017

By end user, the CTMS market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies, and others. The pharmaceutical and biopharmaceutical companies segment is further subsegmented into large pharmaceutical companies and mid-small pharmaceutical companies. The pharmaceutical and biopharmaceutical companies segment is expected to account for the largest share of the CTMS market in 2017. The largest share is attributed to the increasing adoption of CTMS software during drug clinical trials by pharmaceutical and biopharmaceutical companies.

North America is expected to dominate the CTMS market during the forecast period

Geographically, the CTMS market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America is expected to account for the largest share of the global CTMS market during the forecast period (2017-2022). Factors such as rising number of on-going clinical trials (especially in the US), presence of leading players from both demand and supply sides, and government funding for clinical research are contributing to the large share of the North American region.

The major players operating in the CTMS market include Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US).

Stakeholders

• Healthcare IT service providers
• Pharmaceutical/biopharmaceutical companies
• Clinical research organizations
• Research and development (R&D) companies
• Medical device companies
• Business research and consulting service providers
• Academic medical centers/universities/hospitals

      Read the Detailed Article on, "Clinical Trial Management System Market - Global Forecast to 2022", Here..!